Your Community

It’s important to remember that you’re not alone in your treatment journey. As well as your loved ones and your OmniSource team, there is a whole community of families and growth hormone advocacy groups out there.

The following organizations provide information and support services for caregivers and people with growth-related disorders.

These organizations are unaffiliated with Sandoz Inc., which is not responsible for the content of these websites and/or resources referenced therein. These resources are for your reference only.

Growth Hormone Support Groups

The MAGIC Foundation
For information, call 800.362.4423
www.magicfoundation.org

Human Growth Foundation
For information, call 800.451.6434
www.hgfound.org

Pituitary Disorders Education & Support (PDES)
For information, call 734.652.1969
www.pituitarydisorder.net

The Pituitary Society
For information, call 310.988.9486
www.pituitarysociety.org

Turner Syndrome Foundation
For information, call 800.594.4585
www.turnersyndromefoundation.org

Prader-Willi Syndrome Association
For information, call 800.926.4797
www.pwsausa.org

Meet your OmniSource Team

Our OmniSource Case Managers and Nurse Trainers will be with you each step of the way.

Learn More

Get savings support with Co-Pay

Savings support for the journey ahead - eligible patients may pay as little as $0 for their Co-Pay.^*

Learn More

Get started with OmniSource today

Personalized support, each step of the way. Click here to enroll.

**^*Omnitrope Co-Pay Savings Program Eligibility:**

The Omnitrope Co-Pay Savings Program provides up to $5,000 in annual co-pay support for Omnitrope prescriptions. With the Omnitrope Co-pay Savings Program, eligible patients may pay $0 for their co-pay. Eligible patients who are commercially insured may receive co-pay support in the amount of up to $5,000 annually, and patients who are uninsured may receive co-pay support in the amount of up to $417 monthly, with an annual cap of $5,000. Prescription must be for an approved indication. This program is not health insurance. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TRICARE, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Patients can participate for a maximum of 12 months. Eligible patients must have a first use of the program by December 31 of the current year. Omnitrope Co-pay Savings Program may not be combined with any other rebate, coupon, or offer. Omnitrope Co-Pay Savings Program has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.

INDICATIONS

Omnitrope is a prescription medicine that contains human growth hormone and is used to treat:

Children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
Adults with either adult onset or childhood onset GHD

IMPORTANT SAFETY INFORMATION

Who should not take Omnitrope^®?

Omnitrope should not be used by children or adults that have:

a critical illness caused by certain types of heart or stomach surgery, accidental trauma, or a sudden and severe breathing problem (respiratory failure)
Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
cancer or other tumors
allergies to growth hormone or any of the ingredients in the medicine
certain types of eye problems caused by diabetes
closed bone growth plates

What should patients tell their healthcare provider before taking Omnitrope?

Patients should tell their healthcare provider about all of their medical conditions, including if they:

have had heart or stomach surgery, trauma, or serious breathing problems
have or have had cancer or any tumor
have diabetes
take any prescription and non-prescription medicines, steroids, vitamins, or herbal supplements
are pregnant or breastfeeding, or plan to become pregnant or breastfeed

What are the most common side effects of Omnitrope?

local reactions at the injection site (such as pain, numbness, redness and swelling)
headaches
swelling associated with fluid retention
pain in joints and muscle pain
carpal tunnel syndrome
tingling and numbness
high blood sugar (hyperglycemia/diabetes) and sugar in your urine (glucosuria)
unusual skin sensations
low levels of thyroid hormone (hypothyroidism)

Other possible side effects of Omnitrope are:

return of tumor or cancerous growths
headaches, changes in vision, nausea or vomiting (these may be symptoms of raised pressure in the brain which requires immediate medical attention)
hip and knee pain or a limp in children, that can be a sign of slipped capital femoral epiphysis
worsening of pre-existing curvature of the spine in children (scoliosis)
increased ear infections and ear disorders in children with Turner syndrome; check for cardiovascular disorders (hypertension, stroke)
intense pain and tenderness in the abdomen as consequence of an inflammation of the pancreas (pancreatitis)
gasping syndrome (decreased rate of breathing) in children from high levels of benzyl alcohol (an inactive ingredient)
Increased mortality in patients with Prader Willi and acute illness

Please see full Prescribing Information for Omnitrope

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch